{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:12:30Z","timestamp":1765177950249,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2019C03012"],"award-info":[{"award-number":["2019C03012"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670227"],"award-info":[{"award-number":["81670227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20180099"],"award-info":[{"award-number":["Y20180099"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cca.2019.11.001","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T11:11:32Z","timestamp":1574248292000},"page":"201-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Relationship between plasma cancer antigen (CA)-125 level and one-year recurrence of atrial fibrillation after catheter ablation"],"prefix":"10.1016","volume":"502","author":[{"given":"Zhouqing","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohe","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijie","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Jiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.11.001_b0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.11.001_b0010","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.11.001_b0015","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2019.11.001_b0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/europace\/euu007","article-title":"Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation","volume":"16","author":"Providencia","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.cca.2019.11.001_b0025","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-017-0590-z","article-title":"Catheter ablation of atrial fibrillation: an overview for clinicians","author":"Mujovi\u0107","year":"2017","journal-title":"Adv. Therapy"},{"key":"10.1016\/j.cca.2019.11.001_b0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/172460089801300403","article-title":"More than 15 years of CA 125: what is known about the antigen, its structure and its function","volume":"13","author":"O'Brien","year":"1998","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.cca.2019.11.001_b0035","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0735-1097(03)00311-5","article-title":"Serum concentrations of carbohydrate antigen 125 in patients with chronic heart failure","volume":"41","author":"D\u2019Aloia","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2019.11.001_b0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejheart.2004.07.015","article-title":"The significance of CA125 concentrations in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters","volume":"7","author":"Kouris","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cca.2019.11.001_b0045","doi-asserted-by":"crossref","first-page":"e81328","DOI":"10.1371\/journal.pone.0081328","article-title":"Higher carbohydrate antigen 125 concentrations are associated with increased risk of coronary heart disease in elderly chinese: a population-based case-control study","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.11.001_b0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/clc.20868","article-title":"Role of CA-125 in identification of right ventricular failure in chronic obstructive pulmonary disease","volume":"34","author":"Yilmaz","year":"2011","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.cca.2019.11.001_b0055","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10741-013-9402-y","article-title":"Clinical utility of antigen carbohydrate 125 in heart failure","volume":"19","author":"Nunez","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cca.2019.11.001_b0060","article-title":"Cancer antigen-125 plasma concentration as a biomarker of new-onset atrial fibrillation in postmenopausal women","author":"Haruki Sekiguchi","year":"2016","journal-title":"Heart"},{"issue":"Suppl 2","key":"10.1016\/j.cca.2019.11.001_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00059-014-4148-4","article-title":"Cancer antigen 125 concentrations and increased risk of new-onset atrial fibrillation","volume":"40","author":"Yucel","year":"2015","journal-title":"Herz"},{"key":"10.1016\/j.cca.2019.11.001_b0070","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1515\/CCLM.2006.083","article-title":"Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay","volume":"44","author":"Yagmur","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.11.001_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HCO.0b013e3283336d52","article-title":"Persistent atrial fibrillation: current approach and controversies","volume":"25","author":"Parkash","year":"2010","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.cca.2019.11.001_b0080","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0015-0282(16)49333-7","article-title":"Elevated serum concentrations of CA-125 in patients with advanced endometriosis","volume":"45","author":"Barbieri","year":"1986","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2019.11.001_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/europace\/eux013","article-title":"Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis","volume":"20","author":"Njoku","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.cca.2019.11.001_b0090","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1253\/circj.CJ-19-0167","article-title":"U-shaped relationship between left atrium size on echocardiography and 1-year recurrence of atrial fibrillation after radiofrequency catheter ablation- prognostic value study","volume":"83","author":"Wang","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.cca.2019.11.001_b0095","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euw088","article-title":"Association of pre-ablation concentration of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis","author":"Jiang","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.cca.2019.11.001_b0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0002-9378(91)90093-7","article-title":"CA 125 regression: a model for epithelial ovarian cancer response","volume":"165","author":"Buller","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2019.11.001_b0105","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehq142","article-title":"Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure","volume":"31","author":"N\u00fa\u00f1ez","year":"2010","journal-title":"Eur. Heart J."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811932114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811932114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:52:36Z","timestamp":1757861556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811932114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":21,"alternative-id":["S000989811932114X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.11.001","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between plasma cancer antigen (CA)-125 level and one-year recurrence of atrial fibrillation after catheter ablation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}